Editorial: Emerging trends in moyamoya disease: diagnostic and therapeutic innovations
By
Shihao He
Hansen Chen
Rong Wang
Yuanli Zhao
May 29, 2026
Clinical Scorecard: New Developments in Moyamoya Disease: Innovations in Diagnosis and Treatment
At a Glance
Category Detail
Condition Key Mechanisms Chronic stenosis or occlusion of terminal internal carotid arteries; development of fragile collateral networks. Target Population Care Setting
Key Highlights
Emerging epigenetic mechanisms may contribute to MMD pathogenesis. Surgical techniques for revascularization are tailored to individual anatomical and clinical factors. Temporal muscle thickness (TMT) may predict post-operative motor aphasia. Comparative studies on bypass techniques show no clear superiority in short-term outcomes. Guideline-Based Recommendations
Diagnosis
Utilize novel imaging strategies and serum biomarkers for diagnosis. Management
Consider individualized surgical approaches based on patient anatomy and clinical presentation. Monitoring & Follow-up
Implement post-operative surveillance to anticipate neurological symptoms. Risks
Post-operative transient neurological deficits are significant complications. Patient & Prescribing Data
Surgical intervention may not be beneficial for all asymptomatic patients.
Clinical Best Practices
Standardize reporting of hemodynamic endpoints in clinical trials. Incorporate TMT measurement in preoperative assessments. Related Resources & Content
